The Australian Dollar remains steady as traders exercise caution ahead of the Federal Reserve's interest rate decision. Australia’s Treasurer Jim Chalmers criticized the Trump administration’s trade ...

"It's going to be a zigzagging market this year," says Stifel's Barry Bannister.

Alternatives and dynamic asset allocation are defining the new order for private banks seeking to navigate risks and seize new opportunities in response to trade tensions. Private bank chief ...

U.S. stocks stabilised for the second day on Monday, as details of the February U.S. retail sales report calmed some of the worst fears about American consumers. Meanwhile, global stocks pushed higher ...

Fed faces stagflation risks as tariff threats, spending cuts, and rising inflation expectations complicate rate decisions.

In a week when major central banks are expected to remain static, caught in a storm of disruptive U.S. policymaking, the Bank ...

The Bay Area’s 7.2% real wage decline ranked mid-range 11th. The region comprising Alameda, Contra Costa, Marin, San ...

Albany’s biggest battle of the year started in earnest last week, when the state Assembly and Senate released their counters ...

Investors are scrambling to make sense of the on-again, off-again nature of Trump’s tariffs, the Fed’s next moves and ...

When inflation surged in 2022, it was relatively easy to predict central bankers’ next moves: the argument for rising interest rates was clear and relatively unambiguous. Today, trade offs are far ...

The Federal Reserve is expected to keep interest rates unchanged, with focus shifting to future policy guidance. Investors ...

The British pharma company said Monday that it will pay $425 million to Esobiotec once the deal closes, expected in the second quarter of this year. AstraZeneca will pay EsoBiotec up to $575 million ...